JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2476
PUT
Voya Financial
VOYA
$8.86B
| $5M | ﹤0.01% |
+100,000
| New | +$4.74M |
2019 Q1
0 quarters
|
|
2477
PUT
Conagra Brands
CAG
$6.42B
| $4.99M | ﹤0.01% |
+180,000
| New | +$4.13M |
2019 Q1
0 quarters
|
|
|
AMRN
2478
CALL
Amarin Corp
AMRN
$255M
| $4.98M | ﹤0.01% |
+12,000
| New | +$4.33M |
2019 Q1
0 quarters
|
|
|
PRNB
2479
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $4.96M | ﹤0.01% |
145,876
-3,673
| -2% | -$117K |
2018 Q3
2 quarters
|
|
2480
Cboe Global Markets
CBOE
$29.1B
| $4.96M | ﹤0.01% |
51,967
-2,626
| -5% | -$249K |
2013 Q2
23 quarters
|
|
2481
CALL
Boston Properties
BXP
$9.55B
| $4.95M | ﹤0.01% |
+37,000
| New | +$4.75M |
2019 Q1
0 quarters
|
|
|
YARW
2482
Yarrow Bioscience
YARW
$158M
| $4.95M | ﹤0.01% |
175
-24
| -12% | -$576K |
2018 Q1
4 quarters
|
|
2483
PUT
Merit Medical Systems
MMSI
$5.07B
| $4.95M | ﹤0.01% |
+80,000
| New | +$4.54M |
2019 Q1
0 quarters
|
|
2484
Kaiser Aluminum
KALU
$2.51B
| $4.95M | ﹤0.01% |
47,220
-114,849
| -71% | -$11.7M |
2013 Q2
23 quarters
|
|
2485
NACCO Industries
NC
$275M
| $4.94M | ﹤0.01% |
129,231
-18,545
| -13% | -$677K |
2013 Q2
23 quarters
|
|
|
RPAI
2486
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $4.93M | ﹤0.01% |
404,614
-2,333,614
| -85% | -$28.4M |
2015 Q4
13 quarters
|
|
|
FBRX
2487
DELISTED
Forte Biosciences
FBRX
| $4.93M | ﹤0.01% |
1,209
+193
| +19% | +$746K |
2017 Q2
7 quarters
|
|
|
RETA
2488
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $4.92M | ﹤0.01% |
57,624
-27,634
| -32% | -$2.29M |
2016 Q2
11 quarters
|
|
2489
Invesco Dorsey Wright Momentum ETF
PDP
$1.5B
| $4.92M | ﹤0.01% |
86,782
-13,642
| -14% | -$727K |
2013 Q2
23 quarters
|
|
2490
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
| $4.92M | ﹤0.01% |
105,387
+15,083
| +17% | +$682K |
2017 Q2
7 quarters
|
|
2491
Manhattan Associates
MANH
$11.8B
| $4.91M | ﹤0.01% |
89,163
-62,530
| -41% | -$3.2M |
2013 Q2
23 quarters
|
|
2492
PUT
TripAdvisor
TRIP
$999M
| $4.91M | ﹤0.01% |
+95,500
| New | +$5.23M |
2019 Q1
0 quarters
|
|
|
CORR
2493
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $4.91M | ﹤0.01% |
133,619
-55,801
| -29% | -$2.01M |
2016 Q2
11 quarters
|
|
2494
Signet Jewelers
SIG
$3.91B
| $4.9M | ﹤0.01% |
180,535
-115,121
| -39% | -$3.17M |
2013 Q2
23 quarters
|
|
2495
iShares MSCI Poland ETF
EPOL
$837M
| $4.9M | ﹤0.01% |
214,174
+214,019
| +138,077% | +$5.04M |
2015 Q4
13 quarters
|
|
2496
Arcosa
ACA
$7.19B
| $4.9M | ﹤0.01% |
160,394
+68,670
| +75% | +$2.1M |
2018 Q4
1 quarter
|
|
2497
Sunrun
RUN
$1.87B
| $4.9M | ﹤0.01% |
348,464
+198,395
| +132% | +$2.73M |
2016 Q2
11 quarters
|
|
2498
Medifast
MED
$129M
| $4.89M | ﹤0.01% |
38,343
-5,005
| -12% | -$635K |
2013 Q2
23 quarters
|
|
2499
Voyager Therapeutics
VYGR
$152M
| $4.88M | ﹤0.01% |
255,192
-32,839
| -11% | -$428K |
2017 Q3
6 quarters
|
|
2500
PUT
Williams Companies
WMB
$88.5B
| $4.88M | ﹤0.01% |
170,000
-291,100
| -63% | -$7.8M |
2018 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.